Healthcare & Medical Devices Global On demand · 24-48h

Global Endoscope Disinfectant Market Strategic Research Report

Global Endoscope Disinfectant Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Endoscope Disinfectant Market
$8952025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: o-Phthalaldehyde Disinfectant, Peracetic Acid Disinfectant, Sodium Dichloroisocyanurate Disinfectant, Others

By Application: Hospital, Clinic, Research Institution, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Fujifilm, Steris Life Sciences, Olympus, Ecolab, AMTEC, Wassenburg Medical, WEGO, SHINVA, Lionser, Guangzhou AULLAP, Shandong LIRCON, Jiangsu Feiyu

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 113 pages
Market size 2025
$895
Million USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$1276.2
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Endoscope Disinfectant market size is predicted to grow from US$ 895 million in 2025 to US$ 1,268 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Endoscope disinfectants are specialized products designed for the high-level disinfection or sterilization of flexible endoscopes, rigid endoscopes, and their associated accessories following the cleaning process. Common active ingredients include orthophthalaldehyde, peracetic acid, glutaraldehyde, chlorine dioxide, chlorine-based disinfectants, and complex oxidation systems. Key characteristics of these products include a broad spectrum of antimicrobial activity, rapid action, compatibility with the intricate lumen structures of endoscopes, and strict requirements regarding residue control. Furthermore, their effective utilization necessitates integration with established endoscope cleaning and disinfection protocols, automated endoscope reprocessors, and hospital infection control guidelines. In 2025, the global sales volume is projected to reach approximately 28.6 million liters, with an average unit price of approximately $32 per liter and a capacity utilization rate of approximately 73%. Upstream enterprises primarily comprise suppliers of disinfectant raw materials, peroxides, aldehyde-based chemicals, stabilizers, corrosion inhibitors, surfactants, purified water, packaging containers, testing indicators, and hazardous chemical logistics providers. Downstream entities predominantly consist of hospital-based digestive endoscopy centers, respiratory endoscopy centers, urology endoscopy centers, ENT departments, specialized endoscopy diagnostic and treatment centers, private clinics, third-party sterile processing facilities, research institutions, and medical device reprocessing service providers. The gross profit margin for these products stands at approximately 38%. Regarding the product cost structure, active disinfectant ingredients account for 30%; stabilizers and corrosion inhibitors for 12%; purified water and solution preparation for 6%; packaging materials for 10%; quality testing and microbiological validation for 8%; production labor and energy consumption for 7%; regulatory registration and validation documentation for 8%; warehousing and logistics for 9%; and distribution channels and other miscellaneous expenses for 10%. The list of demand drivers includes the need for high-level endoscope disinfection, consumables for automated endoscope reprocessors, hospital infection control measures, support for the growing volume of endoscopic diagnostic and therapeutic procedures, standardization requirements for sterile processing centers, the need for rapid turnaround disinfection cycles, demand for low-residue and low-corrosion products, and requirements for accompanying concentration monitoring solutions. The downstream client base encompasses general hospitals, specialized hospitals, digestive endoscopy centers, respiratory endoscopy centers, health examination centers, dental and ENT clinics, primary healthcare institutions, third-party disinfection service providers, and medical device reprocessing centers. In terms of business opportunities, policy-driven factors stem primarily from heightened requirements for hospital infection control, strengthened standards for endoscope cleaning and disinfection, upgrades in medical quality management, capacity building for endoscopy services at the primary care level, and increasingly stringent compliance reviews for disinfection products used in healthcare institutions. Technological innovation is driven mainly by the development of rapid, high-level disinfection formulations; low-corrosion and corrosion-inhibiting systems; low-odor formulations; real-time concentration monitoring; automated dosing systems; compatibility validation with endoscope equipment; and traceable packaging and labeling. Changes in consumer demand—manifested in hospitals placing greater emphasis on disinfection efficiency, endoscope protection, personnel safety, minimized residual risks, operational simplicity, cost control, and supply stability—are driving the evolution of endoscope disinfectants toward solutions characterized by rapid action, low corrosivity, low irritation, machine compatibility, and robust regulatory documentation support.

Global key Endoscope Disinfectant players cover Fujifilm, Steris Life Sciences, Olympus, Ecolab, AMTEC, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Endoscope Disinfectant market?

What factors are driving Endoscope Disinfectant market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Endoscope Disinfectant market opportunities vary by end market size?

How does Endoscope Disinfectant break out by Type, by Application?

This report presents a comprehensive overview of the global Endoscope Disinfectant market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • o-Phthalaldehyde Disinfectant
  • Peracetic Acid Disinfectant
  • Sodium Dichloroisocyanurate Disinfectant
  • Others

Segment by Component

  • One-Component Disinfectant
  • Two-Component Disinfectant

Segment by Application

  • Hospital
  • Clinic
  • Research Institution
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Endoscope Disinfectant market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Research Institution evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Endoscope Disinfectant Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$895
2025
Forecast
$1276.2
2032
CAGR
5.2%
2025–2032
Regions
5
global
Key companies
FujifilmSteris Life SciencesOlympusEcolabAMTECWassenburg MedicalWEGOSHINVA
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
o-Phthalaldehyde DisinfectantPeracetic Acid DisinfectantSodium Dichloroisocyanurate DisinfectantOthers
By Application
HospitalClinicResearch InstitutionOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 o-Phthalaldehyde Disinfectant
  • 3.1.3 Peracetic Acid Disinfectant
  • 3.1.4 Sodium Dichloroisocyanurate Disinfectant
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Research Institution
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Fujifilm
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Steris Life Sciences
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Olympus
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ecolab
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 AMTEC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Wassenburg Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 WEGO
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SHINVA
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Lionser
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Guangzhou AULLAP
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shandong LIRCON
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Jiangsu Feiyu
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Endoscope Disinfectant market size?
The global Endoscope Disinfectant market is estimated at US$ 895 million in 2025 (base year) and is projected to reach US$ 1.27 billion by 2032.
What growth rate is expected for the Endoscope Disinfectant market through 2032?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 895 million in 2025 to US$ 1.27 billion in 2032, roughly 1.4 times its base-year value.
How is Endoscope Disinfectant defined?
Endoscope disinfectants are specialized products designed for the high-level disinfection or sterilization of flexible endoscopes, rigid endoscopes, and their associated accessories following the cleaning process. Common active ingredients include orthophthalaldehyde, peracetic acid, glutaraldehyde, chlorine dioxide, chlorine-based disinfectants, and complex oxidation systems.
What are the main segments of the Endoscope Disinfectant market by type?
By type, the market is segmented into o-Phthalaldehyde Disinfectant, Peracetic Acid Disinfectant, Sodium Dichloroisocyanurate Disinfectant and Others.
Which applications drive demand in the Endoscope Disinfectant market?
Key applications covered include Hospital, Clinic, Research Institution and Others.
Who are the key players in the Endoscope Disinfectant market?
Key players profiled include Fujifilm, Steris Life Sciences, Olympus, Ecolab, AMTEC, Wassenburg Medical, WEGO and SHINVA, among 12 companies covered in total.
Which regions and countries are covered for Endoscope Disinfectant?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Endoscope Disinfectant market?
What factors are driving Endoscope Disinfectant market growth, globally and by region?
Who should buy the Endoscope Disinfectant market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Research Institution, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Endoscope Disinfectant market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.